House Bill 24

150th General Assembly (Present)

Bill Progress

Signed 6/19/19
Becomes effective upon date of signature of the Governor or upon date specified

Bill Details

1/4/19
Sen. Delcollo
AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO COPAYMENT OR COINSURANCE FOR PRESCRIPTION DRUGS.
This Act would prohibit insurers and pharmacy benefit managers from engaging in the practice of "clawbacks". When the total cost of a prescription drug to an insurer or pharmacy benefits manager is less than a patient's co-pay, the insurer or pharmacy benefits manager keeps the difference in a practice known as a "clawback". According to a March 2018 report issued by the University of Southern California's Schaeffer Center for Health Policy & Economics based on the Center’s analysis of 2013 data from a large commercial insurer combined with data on national average drug reimbursements, almost 25% of filled pharmacy prescriptions involved a patient co-payment that exceeded the average reimbursement paid by the insurer by more than $2.00. The report further noted that overpayments were more likely to occur on claims for generic drugs than brand drugs and that the total overpayments in the Center’s sample amounted to $135 million.
82:57
Not Required
6/19/19

Bill Text

View HTML View PDF
You may need to disable your browser's pop-up blocker to view linked documents.
You may need to disable your browser's pop-up blocker to view linked documents.

Amendments

AmendmentStatusIntroduction DatePrimary SponsorView Details

Committee Reports

DateCommittee# MembersFavorableOn Its MeritsUnfavorable 

Roll Calls

ChamberResultDateVote TypeYesNoNot VotingAbsentPDF

Actions History

DateAction

Legislation Detail Feeds